PGM
GDRX icon

Parian Global Management’s GoodRx Holdings GDRX Stock Holding History

Parian Global Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-114,457
Closed -$4.7M – 38
2021
Q3 		$4.7M Buy
+114,457
New +$4.15M 3.28% 11

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Parian Global Management's GDRX Position: Q4 2021 in Review

Parian Global Management sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 114,457 shares — an estimated $4.7M sold.

Parian Global Management first reported a position in GDRX in Q3 2021 and held it in 1 quarter. The position peaked at $4.7M in Q3 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

  • Parian Global Management reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
  • Parian Global Management sold 114,457 GoodRx Holdings shares in Q4 2021, an estimated $4.7M.
  • Parian Global Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 1 quarter.
  • Parian Global Management's GoodRx Holdings position peaked at $4.7M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Parian Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.